Medicina, 2023 Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal damage requires first-priority medical attention for ...
Ajeeta Anand, Hideki Aoyagi
doaj +2 more sources
Protein and Phosphate Intakes are Associated with Hyperphosphatemia in Hemodialysis Patients at Sanglah Hospital, Bali, Indonesia [PDF]
Majalah Kedokteran Bandung, 2022 Increased chronic kidney disease (CKD) mortality rate is significantly associated with increased blood phosphate levels. Hyperphosphatemia control is one of the main focuses in the management of hemodialysis (HD) patients.
Made Dyah Vismita Indramila Duarsa +3 more
doaj +5 more sources
Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia [PDF]
Медицинский совет, 2020 Mineral-bone disorder in chronic kidney disease (CKD-MBD) is one of the most important factor determining prognosis in dialysis patients. CKD-MBD syndrome occurs at the CKD stage 2 and reaches its maximum in patients with end-stage renal disease ...
A. M. Essaian, A. R. Rind
doaj +2 more sources
Hyperphosphatemia Management in Patients with Chronic Kidney Disease [PDF]
Saudi Pharmaceutical Journal, 2015 Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT ...
Ahmed M. Shaman, Stefan R. Kowalski
doaj +2 more sources
Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis
Frontiers in Medicine, 2022 IntroductionSerum phosphate level is often deranged during critical illness. Hyperphosphatemia, as a marker of disease severity, attracts more and more attention.
Wen-He Zheng
exaly +3 more sources
Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series. [PDF]
J Clin Lab AnalPseudohyperphosphatemia (PHP) is a clinically significant laboratory artifact in patients with multiple myeloma (MM). It is often caused by paraprotein interference with phosphate assays. This systematic review summarizes reported cases, underlying mechanisms, and diagnostic approaches to distinguish spurious from true hyperphosphatemia.
Dabir M +3 more
europepmc +2 more sources
Hyperphosphatemia of chronic kidney disease [PDF]
Kidney International, 2008 Observational studies have determined hyperphosphatemia to be a cardiovascular risk factor in chronic kidney disease. Mechanistic studies have elucidated that hyperphosphatemia is a direct stimulus to vascular calcification, which is one cause of morbid cardiovascular events contributing to the excess mortality of chronic kidney disease.
Hruska, Keith A. +4 more
openaire +4 more sources
Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial [PDF]
Renal FailureBackground This study aimed to evaluate the efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis (MHD).Methods In this phase III, multicenter, randomized, open-label, non-inferiority
Jie Ma +27 more
doaj +2 more sources
Association between serum phosphate levels and outcome among critically ill newborns: a retrospective cohort study [PDF]
Frontiers in PediatricsBackgroundThis study aimed to explore the relationship between serum phosphate levels and clinical outcomes in critically ill neonates.MethodsA retrospective cohort study was conducted using the Pediatric Intensive Care (PIC) database from (2010- 2018 ...
Lisha Bao +5 more
doaj +2 more sources
Clinical Evaluation of Low-Dose Magnesium Carbonate as a Phosphate Binder in Chronic Hemodialysis Patients [PDF]
LifeBackground and Objectives: Hyperphosphatemia is a key component of chronic kidney disease-mineral and bone disorder and is associated with higher rates of cardiovascular events and mortality in patients undergoing dialysis.
Valeri Tzekov +5 more
doaj +2 more sources